These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21603232)

  • 21. Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.
    Hayashi T
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20827419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing.
    Connolly JJ; Hakonarson H
    J Biomed Biotechnol; 2012; 2012():798924. PubMed ID: 22654485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
    Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
    Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.
    López-Pedrera C; Aguirre MÁ; Barbarroja N; Cuadrado MJ
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20936125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocytes, cytokines, inflammation, and immune trafficking.
    Tsokos GC
    Curr Opin Rheumatol; 1994 Sep; 6(5):461-7. PubMed ID: 7993702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathogenesis of systemic lupus erythematosus.
    Childs SG
    Orthop Nurs; 2006; 25(2):140-5; quiz 146-7. PubMed ID: 16572034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research Progress on Regulatory B Cells in Systemic Lupus Erythematosus.
    Wang T; Mei Y; Li Z
    Biomed Res Int; 2019; 2019():7948687. PubMed ID: 31240224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour necrosis factor and other cytokines in murine lupus.
    Theofilopoulos AN; Lawson BR
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I49-55. PubMed ID: 10577973
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy in systemic lupus erythematosus.
    Kyttaris VC; Sfikakis PP; Juang YT; Tsokos GC
    Curr Gene Ther; 2005 Dec; 5(6):677-84. PubMed ID: 16457656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal macrophages in mucosal immunity and their role in systemic lupus erythematosus disease.
    Pan F; Tang W; Zhou Z; Gilkeson G; Lang R; Jiang W
    Lupus; 2018 Oct; 27(12):1898-1902. PubMed ID: 30223707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Etiopathogenesis of systemic lupus erythematosus].
    Mathian A
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S298-301. PubMed ID: 17964004
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disseminated lupus erythematosis: current therapies and future hopes].
    Houssiau FA
    Bull Mem Acad R Med Belg; 2005; 160(5-6):329-35. PubMed ID: 16465788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunopathology and the gene therapy of lupus.
    Mageed RA; Prud'homme GJ
    Gene Ther; 2003 May; 10(10):861-74. PubMed ID: 12732872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoregulatory circuits and potential treatment of connective tissue diseases.
    Alcocer-Varela J; Llorente L; Alarcón-Segovia D
    Int Arch Allergy Immunol; 1996 Dec; 111(4):348-54. PubMed ID: 8957107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinuclear antibody-negative systemic lupus erythematosus: revisited.
    Kaur S; Thami GP
    Indian J Pediatr; 2003 Feb; 70(2):185-6. PubMed ID: 12661819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytokines and lupus].
    Emilie D; Llorente L; Galanaud P
    Ann Med Interne (Paris); 1996; 147(7):480-4. PubMed ID: 9092358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine polymorphisms in systemic lupus erythematosus and Sjögren's syndrome.
    Magnusson V; Nakken B; Bolstad AI; Alarcón-Riquelme ME
    Scand J Immunol; 2001; 54(1-2):55-61. PubMed ID: 11439148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
    Front Immunol; 2020; 11():1047. PubMed ID: 32625200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus.
    Yu SL; Kuan WP; Wong CK; Li EK; Tam LS
    Clin Dev Immunol; 2012; 2012():715190. PubMed ID: 22312407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.